Comirnaty JN.1 ≥12 years and older formulation (pre-filled syringe and multidose vial [grey cap])

Registered for use in people aged 12 years and above.

COVID-19 vaccine containing nucleoside-modified mRNA encoding the spike glycoproteins of SARS-CoV-2 JN.1 strain.

Multi-dose vial

Multi dose vial without preservative. Each vial contains 6 doses in 2.25mL.  Does not require dilution.

Pre-filled syringe

Pre-filled syringe without preservative containing 0.3 mL of concentrated suspension for injection vaccine. Requires no dilution. 1 dose per syringe is available.

Each 0.3 mL dose contains:

• 30 µg mRNA encoding the SARS-CoV-2 JN.1 spike glycoprotein
• ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate) (ALC-0315)
• 2-[(polyethylene glycol)-2000]-N,N-ditetradecylacetamide (ALC-0159)
• Distearoylphosphatidylcholine (DSPC)
• Cholesterol
• Trometamol
• Trometamol hydrochloride
• Sucrose
• Water for injections

For Product Information and Consumer Medicine Information about Comirnaty JN.1 visit the Therapeutic Goods Administration website.